Aug 8 |
Gilead Sciences Announces Second Quarter 2024 Financial Results
|
Aug 8 |
Wall Street Rallies As Economic Concerns Recede, Tech Flexes Its Muscles, Semiconductors Soar: What's Driving Markets Thursday?
|
Aug 8 |
Closing the HIV Diagnosis Gap in Germany with Gilead Sciences
|
Aug 7 |
Gilead Sciences Q2 Earnings Preview: Focus on CAR-T market and oncology
|
Aug 5 |
Gilead's New Anti-Obesity Drug: The Real Reason Behind The 25% Stock Surge?
|
Aug 5 |
Countdown to Gilead (GILD) Q2 Earnings: Wall Street Forecasts for Key Metrics
|
Aug 5 |
Should We Be Cautious About Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE Of 2.6%?
|
Aug 4 |
Wall Street Breakfast: The Week Ahead
|
Aug 3 |
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
|
Aug 2 |
Q3’s Rising Stars: 3 Nasdaq Stocks for Your Must-Watch List
|